These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24487722)
21. Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: a role for combined anti-angiogenesis and immunotherapy. Gyorffy S; Palmer K; Podor TJ; Hitt M; Gauldie J J Immunol; 2001 May; 166(10):6212-7. PubMed ID: 11342643 [TBL] [Abstract][Full Text] [Related]
22. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates. Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415 [TBL] [Abstract][Full Text] [Related]
23. Combination of Caspy2 and IP-10 gene therapy significantly improves therapeutic efficacy against murine malignant neoplasm growth and metastasis. Zhang N; Yang Y; Cheng L; Zhang XM; Zhang S; Wang W; Liu SY; Wang SY; Wang RB; Xu WJ; Dai L; Yan N; Fan P; Dai LX; Tian HW; Liu L; Deng HX Hum Gene Ther; 2012 Aug; 23(8):837-46. PubMed ID: 22548488 [TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Winkelhake JL; Stampfl S; Zimmerman RJ Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953 [TBL] [Abstract][Full Text] [Related]
25. THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanoma. Ophir R; Moalem G; Pecht M; Shashoua M; Rashid G; Ben-Efraim S; Trainin N; Burstein Y; Keisari Y J Immunother; 1999 Mar; 22(2):103-13. PubMed ID: 10093035 [TBL] [Abstract][Full Text] [Related]
26. In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1 beta. II. Mechanism of inhibition: the role of polymorphonuclear leukocytes. Neville ME; Pezzella KM; Schmidt K; Galbraith W; Ackerman N Cytokine; 1990 Nov; 2(6):456-63. PubMed ID: 1966551 [TBL] [Abstract][Full Text] [Related]
27. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects. Sundstedt A; Celander M; Ohman MW; Forsberg G; Hedlund G Int Immunopharmacol; 2009 Aug; 9(9):1063-70. PubMed ID: 19410661 [TBL] [Abstract][Full Text] [Related]
29. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Myers DR; Abram CL; Wildes D; Belwafa A; Welsh AMN; Schulze CJ; Choy TJ; Nguyen T; Omaque N; Hu Y; Singh M; Hansen R; Goldsmith MA; Quintana E; Smith JAM; Lowell CA Front Immunol; 2020; 11():576310. PubMed ID: 33133093 [TBL] [Abstract][Full Text] [Related]
30. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033 [TBL] [Abstract][Full Text] [Related]
31. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells. Wang YQ; Ugai S; Shimozato O; Yu L; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Tagawa M Int J Cancer; 2003 Jul; 105(6):820-4. PubMed ID: 12767068 [TBL] [Abstract][Full Text] [Related]
32. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558 [TBL] [Abstract][Full Text] [Related]
33. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor. Björkdahl O; Dohlsten M; Sjögren HO Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695 [TBL] [Abstract][Full Text] [Related]
34. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide. Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352 [TBL] [Abstract][Full Text] [Related]
35. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533 [TBL] [Abstract][Full Text] [Related]
36. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. Gold JE; Zachary DT; Osband ME Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164 [TBL] [Abstract][Full Text] [Related]
38. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: characteristics of killer cells generated in situ. Lala PK; Elkashab M; Kerbel RS; Parhar RS Int Immunol; 1990; 2(12):1149-58. PubMed ID: 2090199 [TBL] [Abstract][Full Text] [Related]
39. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534 [TBL] [Abstract][Full Text] [Related]
40. Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy. Martins F; Stalder G; Obeid M Neoplasia; 2018 Feb; 20(2):193-196. PubMed ID: 29287248 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]